09:08 CHINA PHARMA<01093> - Announcement The Stock Exchange of Hong Kong Limited takes no responsibilities for the contents of this announcement, makes no representation as to its accuracy or completeness and expressly disclaims any liability whatsoever for any loss however arising from or in reliance upon the whole or any part of the contents of this announcement. China Pharmaceutical Group Limited (Incorporated in Hong Kong with limited liability) (Stock Code: 1093) EXTRAORDINARY GENERAL MEETING HELD ON 21ST FEBRUARY 2005 POLL RESULTS At the extraordinary general meeting of the Company held on 21st February 2005 ("EGM"), the ordinary resolution to approve the Continuing Connected Transactions and the respective annual caps was duly passed by the Independent Shareholders by way of poll. Reference is made to the circular of China Pharmaceutical Group Limited ("Company") dated 24th January 2005 ("Circular") in relation to the Continuing Connected Transactions (including the Chemical Product Transactions, Corn Refined Product Transactions and the Agency Agreement) and the respective annual caps. Unless otherwise defined, terms used in this announcement shall have the same meanings as defined in the Circular. The Board is pleased to announce that at the EGM held on 21st February 2005, the ordinary resolution proposed to approve the Continuing Connected Transactions and the respective annual caps ("Ordinary Resolution") was duly passed by the Independent Shareholders by way of poll. The Company's share registrar, Secretaries Limited, was appointed as scrutineer of the vote-taking at the EGM. The poll result in respect of the Ordinary Resolution passed at the EGM was as follows: No. of Votes (%) Ordinary Resolution For Against To approve: (a) the Chemical Product Transactions and the relevant annual caps; (b) the Corn Refined Product Transactions and the relevant annual caps; and (c) the Agency Agreements and the relevant annual caps. 212,670,066 (100%) NIL (0%) The resolution was duly passed as an ordinary resolution. As at the date of the EGM, the total number of issued shares of the Company was 1,538,124,661 Shares. In view of the interests of SPG in the Continuing Connected Transactions, SPG and its associates (as defined in the Listing Rules) who beneficially own an aggregate of 783,316,161 Shares, representing approximately 50.93% of the issued share capital of the Company, abstained from voting on the Ordinary Resolution. The total number of Shares entitling the Independent Shareholders to attend and vote for or against the Ordinary Resolution at the EGM was 754,808,500 Shares, representing approximately 49.07% of the Company's total number of Shares in issue, and the total number of issued shares of the Company entitling the holders thereof to attend and vote only against the Ordinary Resolution at the EGM is nil. By Order of the Board Cai Dong Chen Chairman Hong Kong, 21st February 2005 As at the date of this announcement, the Company comprises of five executive Directors, namely CAI Dong Chen (Chairman), DING Er Gang, FENG Zhen Ying, , WEI Fu Min, and YUE Jin; one non-executive director, namely LEE Ka Sze, Carmelo; and four independent non-executive Directors, namely CHAN Siu Keung, Leonard, GUO Shi Chang, HUO Zhen Xing, and QI Mou Jia.